# The Effect of Selective Oxytocin Receptor Inhibitors on Endometriosis-related Pain

> **NCT05382143** · PHASE2 · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 10 (estimated)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** Atosiban

## Key facts

- **NCT ID:** NCT05382143
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2022-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05382143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05382143, "The Effect of Selective Oxytocin Receptor Inhibitors on Endometriosis-related Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05382143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*